| Baseline | Follow-up | p |
---|---|---|---|
Age, years | 13.7 (10.0–16.8) | 14.6 (10.9–17.8) | <0.0001*** |
BMI SDS | 2.80 (1.49–3.85) | 2.56 (0.18–4.68) | 0.001** |
VAT, cm3 | 83 (21–361) | 73 (15–396) | 0.01* |
SAT, cm3 | 282 (97–518) | 262 (74–527) | 0.14 |
LFC, % | 3.0 (0.5–67.0) | 3.0 (0.5–32.0) | 0.01* |
Hepatic steatosis, fraction | 28Â % (11/40) | 20Â % (8/40) | 0.26 |
MFC, % | 7.4 (1.2–26.3) | 4.8 (0.5–39.6) | 0.01* |
Muscle steatosis, fraction | 75Â % (30/40) | 45Â % (18/40) | 0.007** |
Triglyceride, mmol/l | 0.9 (0.2–2.3) | 1.0 (0.3–2.0) | 0.78 |
HDL cholesterol, mmol/l | 1.2 (0.7–1.7) | 1.2 (0.8–2.1) | 0.03* |
LDL cholesterol, mmol/l | 2.3 (1.1–4.2) | 2.4 (1.0–3.8) | 0.02* |
Non-HDL cholesterol, mmol/l | 2.8 (1.2–4.7) | 2.8 (1.2–4.4) | 0.02* |
Plasma glucose, mmol/l | 5.1 (4.2–6.2) | 5.1 (4.4–5.9) | 0.42 |
Serum insulin, pmol/l | 83 (11–271) | 87 (14–226) | 0.99 |
HbA1c, mmol/l | 35 (28–42) | 34 (26–40) | 0.04* |
ALT, U/l | 22 (11–126) | 22 (10–69) | 0.67 |
GGT, U/l | 18 (5–134) | 16 (9–33) | 0.72 |